Related Experiment Videos
Estimation issues in clinical trials and overviews
1Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, U.K.
Statistics in Medicine
|June 1, 1990
Summary
This study explores the use and interpretation of treatment effect estimates in clinical trials. It addresses challenges in confidence intervals, publication bias, and meta-analysis models for accurate results.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Evidence-Based Medicine
Background:
- Shift in clinical trial reporting from significance testing to point and interval estimates of treatment effect.
- Need for critical examination of conventional estimation methods and their interpretation.
Purpose of the Study:
- To examine issues affecting the use and interpretation of conventional estimation methods in clinical trials.
- To discuss the role and interpretation of confidence intervals, Bayesian probability intervals, and potential biases in treatment effect estimation.
Main Methods:
- Review and discussion of statistical concepts related to estimation in clinical trials.
- Illustrative examples drawn from recent cardiovascular disease trials.
Main Results:
- Frequentist confidence intervals may be misinterpreted; Bayesian probability intervals could offer an alternative.
- Early stopping and publication bias can lead to exaggerated estimates.
- Subgroup analyses require careful methods for realistic estimates.
- Controversies in meta-analysis models (fixed vs. random effects) impact overall estimation.
Conclusions:
- Accurate interpretation of treatment effect estimates is crucial for reliable clinical trial reporting.
- Addressing issues like confidence interval interpretation, publication bias, and meta-analysis models is essential for unbiased evidence.
- Emphasis on estimation may encourage larger sample sizes, improving study power.